Cohere Health

Sells an AI-powered clinical intelligence platform (Cohere Unify) to health insurers to automate and speed prior authorization and utilization management, and increasingly payment integrity, appeals, care management, claims operations, and quality. Its ML/agentic-AI decisioning auto-approves ~85-90% of authorization requests in real time, digitizes payer medical policies, and exposes FHIR-based prior-auth APIs (Cohere Connect) that help plans meet the January 2027 CMS-0057 interoperability mandates. Processes 15M+ prior-auth submissions and ~47M payer-provider interactions annually across 600K+ providers, with Humana as anchor customer. As of January 2026 it is also one of six CMS-selected technology vendors running the Medicare WISeR (Wasteful and Inappropriate Service Reduction) Model, covering Texas — its first direct traditional-Medicare (FFS) footprint. In February 2026 it opened a Global Capability Center in Hyderabad, India spanning AI/ML engineering, data science, payment integrity, clinical operations, claims auditing, client support, and compliance.

Stated: use clinically trained, agentic AI to make prior authorization instant and transparent, then expand Cohere Unify from utilization management into every clinical-adjacent health-plan operation (payment integrity, appeals, care management, claims ops, quality) as a single coordinated intelligence layer. Inferred: (1) ride the CMS-0057 regulatory wave — sell FHIR ePA APIs and compliance readiness as the wedge before the Jan 2027 mandate, cemented by its HL7 Da Vinci steering-committee role and public CMS-initiative endorsements; (2) diversify payer mix into government business — the WISeR Model contract (Texas, 2026-2031) makes CMS itself a customer and plants a flag in traditional Medicare; (3) 'shift right' from pre-care into post-service claims via the ZignaAI acquisition and Validate/Surface products, capturing payment-integrity budgets; (4) build a global operating model — the Hyderabad GCC concentrates AI/ML engineering, claims auditing, and clinical ops offshore to protect margins as transaction volumes scale; (5) convert authorization data exhaust into care-management and rising-risk products, repositioning from PA vendor to full clinical-decisioning platform before political pressure shrinks the standalone PA market.

Proprietary corpus of digitized payer medical policies plus outcome-labeled decision data from 15M+ annual prior-auth submissions and ~47M payer-provider interactions; deep multi-year Humana integration and 10+ health-plan deployments that are costly to rip out; unique-among-startups federal positioning (one of six CMS WISeR vendors, HL7 Da Vinci steering committee, CHAI membership, CMS ePA-initiative alignment); and a trust record (94% provider satisfaction, multiple KLAS Points of Light) that new entrants cannot quickly replicate in a compliance-sensitive domain.